Log in
Enquire now
‌

US Patent 9365568 Pyrrolopyridines as kinase inhibitors

Patent 9365568 was granted and assigned to Array Biopharma Inc. on June, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Array Biopharma Inc.
Array Biopharma Inc.
0
Current Assignee
Array Biopharma Inc.
Array Biopharma Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
93655680
Patent Inventor Names
Peter J. Mohr0
Yvan Le Huerou0
Bin Wang0
Eli M. Wallace0
Indrani W. Gunawardana0
James F. Blake0
Mark Joseph Chicarelli0
Michael Lyon0
Date of Patent
June 14, 2016
0
Patent Application Number
145916910
Date Filed
January 7, 2015
0
Patent Citations Received
‌
US Patent 12083114 Inhibitors of SARM1 in combination with neuro-protective agents
0
Patent Primary Examiner
‌
Sun Jae Yoo
0
Patent abstract

Compounds of Formula I are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9365568 Pyrrolopyridines as kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.